Evidence map›Paper›PMID 33173740›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Nidogen 1-Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1.

Xiaowen Mao, Sze Keong Tey, Cherlie Lot Sum Yeung, Ernest Man Lok Kwong, Yi Man Eva Fung, Clive Yik Sham Chung, Lung-Yi Mak, Danny Ka Ho Wong, Man-Fung Yuen, James Chung Man Ho and 10 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Non-invasive model for predicting future lung metastasis of hepatocellular carcinoma based on imaging heterogeneity analysis.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. PDPNCell communication and signaling : CCS · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia.International journal of molecular sciences · 2025
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Xiaowen MaoDepartment of Pathology, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Sze Keong TeyDepartment of Pathology, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Cherlie Lot Sum YeungDepartment of Pathology, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Ernest Man Lok KwongDepartment of Pathology, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Yi Man Eva FungDepartment of Chemistry, State Key Laboratory of Synthetic Chemistry The University of Hong Kong Pokfulam Hong Kong.
Clive Yik Sham ChungSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Lung-Yi MakDepartment of Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Danny Ka Ho WongDepartment of Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Man-Fung YuenDepartment of Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
James Chung Man HoDepartment of Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Herbert PangSchool of Public Health, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Maria Pik WongDepartment of Pathology, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.
Carmen Oi-Ning LeungDepartment of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Kowloon Hong Kong.
Terence Kin Wah LeeDepartment of Applied Biology and Chemical Technology The Hong Kong Polytechnic University Kowloon Hong Kong.
Victor MaDepartment of Clinical Oncology Queen Elizabeth Hospital Kowloon Hong Kong.
William Chi-Shing ChoDepartment of Clinical Oncology Queen Elizabeth Hospital Kowloon Hong Kong.
Peihua CaoDepartment of Hepatobiliary Surgery II, Zhujiang Hospital Southern Medical University Guangzhou 510280 China.
Xiaoping XuDepartment of Hepatobiliary Surgery II, Zhujiang Hospital Southern Medical University Guangzhou 510280 China.
Yi GaoDepartment of Hepatobiliary Surgery II, Zhujiang Hospital Southern Medical University Guangzhou 510280 China.
Judy Wai Ping YamDepartment of Pathology, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong.ORCID https://orcid.org/0000-0002-5637-121X
Chinese University of Hong Kong · HKZhujiang Hospital · CNHong Kong Polytechnic University · HKQueen Elizabeth Hospital · CNUniversity of Hong Kong · HKState Key Laboratory of Synthetic Chemistry · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In hepatocellular carcinoma (HCC) patients with extrahepatic metastasis, the lung is the most frequent site of metastasis. However, how the lung microenvironment favors disseminated cells remains unclear. Here, it is found that nidogen 1 (NID1) in metastatic HCC cell-derived extracellular vesicles (EVs) promotes pre-metastatic niche formation in the lung by enhancing angiogenesis and pulmonary endothelial permeability to facilitate colonization of tumor cells and extrahepatic metastasis. EV-NID1 also activates fibroblasts, which secrete tumor necrosis factor receptor 1 (TNFR1), facilitate lung colonization of tumor cells, and augment HCC cell growth and motility. Administration of anti-TNFR1 antibody effectively diminishes lung metastasis induced by the metastatic HCC cell-derived EVs in mice. In the clinical perspective, analysis of serum EV-NID1 and TNFR1 in HCC patients reveals their positive correlation and association with tumor stages suggesting the potential of these molecules as noninvasive biomarkers for the early detection of HCC. In conclusion, these results demonstrate the interplay of HCC EVs and activated fibroblasts in pre-metastatic niche formation and how blockage of their functions inhibits distant metastasis to the lungs. This study offers promise for the new direction of HCC treatment by targeting oncogenic EV components and their mediated pathways.

Indexed as

extracellular vesicleshepatocellular carcinomanidogen 1pre‐metastatic nichetumor necrosis factor receptor 1

Identifiers

PMID33173740
PMCPMC7640351
OpenAlexW3060747957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.